RenalTech International
This article was originally published in The Gray Sheet
Executive Summary
Fourth-quarter 510(k) submission is planned for a polymer-based device intended to enhance removal of middle molecular weight blood toxins. Designed for use during dialysis, the device is expected to help reduce side effects or mobidity associated with current dialysis procedures, the company says